Literature DB >> 116085

Aspartylglycosaminuria in Northern Norway in eight patients: clinical heterogeneity and variations with the diet.

O Borud, J H Strömme, S O Lie, K H Torp.   

Abstract

Urinary excretion of aspartylglycosamines was investigated in eight patients by semiquantitative thin-layer chromatography, and bound glycosamines by a quantitative photometric method (Elson-Morgan reaction). Each patient showed a fairly constant level, relative to the creatinine, of aspartylglycosamines in urine. The least retarded patient, aged 31, excreted about 350 mg/g creatinine, one-third of that found in two severely retarded young patients, aged 4 and 7 years (1400 and 940 mg/g creatinine, respectively). Three days on a low-protein diet did not change the aspartylglycosamine excretion in the patient showing the highest excretion rate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 116085     DOI: 10.1007/bf01805680

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Fractionation and characterization of acidic ogligosaccharides and glycopeptides from normal and pathological urines.

Authors:  G Grecker
Journal:  J Chromatogr       Date:  1977-11-01

2.  Fucosidosis.

Authors:  G Dawson; G C Tsay
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

3.  Mannosidosis. Storage material, alpha-mannosidase specificity and diagnostic methods.

Authors:  A Lundblad; P Masson; N E Nordén; S Svensson; P Ockerman
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

Review 4.  Aspartylglycosaminuria. Analysis of thirty-four patients.

Authors:  S Autio
Journal:  J Ment Defic Res       Date:  1972

Review 5.  Rapid screening methods for the detection of inherited and acquired aminoacidopathies.

Authors:  A Saifer
Journal:  Adv Clin Chem       Date:  1971       Impact factor: 5.394

6.  Aspartylglycosaminuria. An inborn error of metabolism associated with mental defect.

Authors:  R J Pollitt; F A Jenner; H Merskey
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

7.  Glycoasparagine metabolites in patients with aspartylglycosaminuria: comparison between English and Finnish patients with special reference to storage materials.

Authors:  J Palo; R J Pollitt; K M Pretty; H Savolainen
Journal:  Clin Chim Acta       Date:  1973-08-17       Impact factor: 3.786

8.  Aspartylglucosaminuria: psychomotor retardation masquerading as a mucopolysaccharidosis.

Authors:  J N Isenberg; H L Sharp
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

9.  Enzymatic diagnosis and carrier detection of aspartylglucosaminuria using blood samples.

Authors:  P Aula; K Raivio; S Autio
Journal:  Pediatr Res       Date:  1976-06       Impact factor: 3.756

10.  An assay for total hexosamine and a differential assay for glucosamine and galactosamine.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Clin Biochem       Date:  1976-12       Impact factor: 3.281

View more
  2 in total

1.  Purification and structure of human liver aspartylglucosaminidase.

Authors:  J W Rip; M B Coulter-Mackie; C A Rupar; B A Gordon
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

2.  Variation of urinary excretion of aspartylglucosamine and associated clinical findings in aspartyglucosaminuria.

Authors:  P Aula; K O Raivio; P Maury
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.